Case file
Payday & personal loans
Complaint 8214797 Avadyne Health
Explained- Product
- Payday loan, title loan, personal loan, or advance loan · Installment loan
- Detail
- Personal information incorrect
- Filed by
- Referral
- Company's answer
- Closed with explanation
- On time
- Yes, within 15 days
- Jan 24, 2024Complaint received
- Jan 24, 2024Sent to Avadyne Health
- AnsweredClosed with explanation
Closed with explanation: the company replied and explained its position, but gave no money back and changed nothing. The consumer's own description is not published with this record.
More Avadyne Health complaints about incorrect information on your report
| Received | About | Issue | State | Answer | On time |
|---|
| Jun 13, 2025 | Credit reporting | Incorrect information on your reportOld information reappears or never goes away | TN | Explained | Yes |
| May 15, 2025 | Credit reporting | Incorrect information on your reportInformation belongs to someone else | IA | Explained | Yes |
| Apr 11, 2025 | Credit reporting | Incorrect information on your reportAccount information incorrect | KS | Explained | Yes |
| Jan 12, 2025 | Credit reporting | Incorrect information on your reportInformation belongs to someone else | DC | Explained | Yes |
| May 21, 2024 | Credit reporting | Incorrect information on your reportInformation belongs to someone else | PA | Explained | Yes |
| Aug 30, 2023 | Credit reporting | Incorrect information on your reportAccount status incorrect | MO | Explained | Yes |
| Mar 27, 2023 | Credit reporting | Incorrect information on your reportAccount information incorrect | PA | Explained | Yes |
| Feb 12, 2023 | Credit reporting | Incorrect information on your reportAccount status incorrect | NJ | Explained | Yes |
| Nov 13, 2022 | Credit reporting | Incorrect information on your reportAccount information incorrect | PA | Explained | Yes |
| Nov 2, 2022 | Credit reporting | Incorrect information on your reportInformation belongs to someone else | GA | Explained | No |
Discuss this complaint
No comments yet. Start the conversation - questions are welcome too.